Loading data for OVID — first visit, this takes a few seconds.
Ovid Therapeutics Inc. (OVID)
NasdaqCM: OVID
· 实时价格 · USD
2.80
+0.02 (0.72%)
收盘价： Sep 09, 2026, 1:42 PM
股价、关键数字和最新消息，都在这一页。
Ovid Therapeutics Inc.（OVID）股价、分析与数据
暂无数据
| 买价 | 1.99 |
| 市值 | 534M |
| 营收（TTM） | 1.58M |
| 净利润（TTM） | -34.5M |
| 0.25 | |
| -0.21 | |
| n/a | |
| -6.91 | |
| 市净率（TTM） | 2.41 |
| 市销率（TTM） | 337.42 |
| 财报日期 | Nov 11, 2026 |
| 卖价 | 3.5 |
| 成交量 | 1,066,037 |
| 20日均量 | 2,276,058 |
| 开盘价 | 2.74 |
| 前收盘价 | 2.78 |
| 日内区间 | 2.71 - 2.83 |
| 52周区间 | 1.12 - 3.10 |
| 分析师 | n/a |
| 目标价 | n/a |
| 分红 | n/a |
| 除息日 | n/a |
关于 OVID
Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of small molecule medicines for brain disorders including epilepsies and seizure-related neurological disorders in the United States. The company is developing OV329, a GABA-AT inhibitor which is in Phase 1 clinical trials for the treatment of adult and infant drug-resistant epilepsies; and OV4071, a first-in-human oral potassium-chloride cotransporter 2 direct activa...
公司完整简介财报意外
Ovid Therapeutics 已于 Aug 13, 2026 发布季度财报：
- 营收为 $733K 低于预期 $0, ， -88.31% 同比下滑.
- 每股收益为 -0.08 超出预期 0.02, ， -33.33% 同比下滑.
第 1 页，共 2 页